Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Campaigns were Conducted against the Ministry because of its Minister's Stances; some Dossiers were Excluded from the Cabinet's Agenda

 
Caretaker Deputy Prime Minister and Health Minister Ghassan Hasbani stressed that false information has been circulated concerning the financial ceilings and the performance of the Lebanese Forces ministers was criticized, while these latter ministers have proved to be an example that should be followed in the government.  

Hasbani was quoted as saying by the state-run Tele Liban the financial prosecutor heard Tuesday two counselors who were found innocent. “We respect any judicial decision taken and the allegations and what was said about us were found to be wrong,” Hasbani added.

The financial ceilings

Hasbani explained the issue of the financial ceilings saying that in the previous years no mechanism was adopted for these ceilings which were set without clear standards. “We have adopted a mechanism based on the size of the hospital, the real number of beds, the services provided and the cost of bed. We found out that the declared number of beds in the syndicate was incorrect. The head of the association was informed and we adopted the existing number of beds in each hospital.”

“The mechanism for the financial ceilings that we have submitted to the cabinet since 2017 was not included in the agenda. Therefore, we referred to the powers stipulated in the law that give the minister the right to amend the financial ceilings as needed,” the Minister of Public Health added.

No shortage in drugs

As for drug shortages, Hasbani noted that there was no lack of free drugs in Quarantine and all what has been circulated was not true. There are many drugs of which prices were cut off according to a specific mechanism.

“The drugs available in the Lebanese markets are from all the countries and abide by all mechanisms and conditions. 25 thousand patients benefit from the drugs provided by the Ministry of Public Health,” Hasbani added.

The Ministry of Public Health conducts permanent awareness campaigns to prevent diseases. An awareness campaign on obesity will be launched soon, knowing that these campaigns receive technical and financial support from the World Health Organization and the World Bank respectively.
 
Food Safety


Hasbani tackled food safety saying that the Ministry of Public Health conducted 29 thousand inspections and issued 10 thousand warnings. “We have never heard about them in the media because they tarnish the reputation of the Lebanese food sector. We have also launched the Application “Ballegh Lel Soha” that enables the citizens to report to the ministry on any violation,” Hasbani noted
    1
ATC Name B/G Ingredients Dosage Form Price
J01DD13 ZAKON G Cefpodoxime (proxetil) - 100mg/5ml 100mg/5ml Powder for suspension 1,116,733 L.L
P02CA03 ZALBENDOL G Albendazole - 200mg 200mg Tablet 127,985 L.L
C08DB01 ZALDEM G Diltiazem HCl - 60mg 60mg Tablet, scored 199,657 L.L
C08DB01 ZALDEM CR G Diltiazem HCl - 180mg 180mg Capsule, controlled release 966,287 L.L
C08DB01 ZALDEM CR G Diltiazem HCl - 120mg 120mg Capsule, controlled release 517,059 L.L
C08DB01 ZALDEM CR G Diltiazem HCl - 240mg 240mg Capsule, controlled release 1,002,123 L.L
N02AJ13 ZALDIAR B Paracetamol - 325mg, Tramadol - 37.5mg Tablet, film coated 704,173 L.L
S01GX08 ZALERG G Ketotifen - 0.25mg/ml 0.25mg/ml Drops solution 446,156 L.L
N05AX12 ZALONIL G Aripiprazole - 10mg 10mg Tablet, orodispersible 1,988,887 L.L
N05AX12 ZALONIL G Aripiprazole - 15mg 15mg Tablet, orodispersible 2,426,980 L.L
L01XX44 ZALTRAP BioTech Aflibercept - 100mg/4ml 100mg/4ml Injectable concentrate for solution 35,658,713 L.L
L01XX44 ZALTRAP BioTech Aflibercept - 100mg/4ml 100mg/4ml Injectable concentrate for solution 35,658,713 L.L
L01XX44 ZALTRAP BioTech Aflibercept - 200mg/8ml 200mg/8ml Injectable concentrate for solution 63,807,499 L.L
L01XX44 ZALTRAP BioTech Aflibercept - 200mg/8ml 200mg/8ml Injectable concentrate for solution 63,807,499 L.L
B01AF01 ZARLAN G Rivaroxaban - 15mg 15mg Tablet, film coated 2,015,764 L.L
B01AF01 ZARLAN G Rivaroxaban - 15mg 15mg Tablet, film coated 1,343,843 L.L
B01AF01 ZARLAN G Rivaroxaban - 20mg 20mg Tablet, film coated 1,343,843 L.L
B01AF01 ZARLAN G Rivaroxaban - 10mg 10mg Tablet, film coated 1,439,255 L.L
L03AA02 ZARZIO BioTech Filgrastim - 300mcg/0.5ml 30MU/0.5ml Injectable solution 13,053,190 L.L
L03AA02 ZARZIO BioTech Filgrastim - 300mcg/0.5ml 30MU/0.5ml Injectable solution 13,053,190 L.L
L01DB06 ZAVEDOS B Idarubicin HCl - 10mg 10mg Injectable freeze dried material 12,071,013 L.L
J01DD52 ZAVICEFTA B Ceftazidime - 2g, Avibactam - 0.5g Injectable powder for concentrate for solution 101,659,975 L.L
N03AF04 ZEBINIX B Eslicarbazepine acetate - 800mg 800mg Tablet 10,075,439 L.L
N06AB10 ZELAX 10 G Escitalopram (oxalate) - 10mg 10mg Caplet 833,182 L.L
N06AB10 ZELAX 20 G Escitalopram (oxalate) - 20mg 20mg Caplet 1,544,075 L.L
L01EC01 ZELBORAF B Vemurafenib - 240mg 240mg Tablet, film coated L.L
L01EC01 ZELBORAF B Vemurafenib - 240mg 240mg Tablet, film coated 142,041,587 L.L
C10AX09 ZEMIL G Ezetimibe - 10mg 10mg Tablet 944,529 L.L
P02CA03 ZENTEL B Albendazole - 400mg 400mg Tablet 169,324 L.L
R03AK12 ZEPHIRUS B Salmeterol - 20mcg, Budesonide - 120mcg Capsule, inhalation 1,412,378 L.L
    1
Sitemap
© Copyrights reserved to Ministry of Public Health 2026